Navigation Links
In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study
Date:6/17/2008

SAN DIEGO, June 17 /PRNewswire/ -- Leading a trend of unprecedented growth in biotechnology innovation, targeted therapies with companion molecular diagnostics have built significant traction in the past year in terms of development and usage, according to a new Deloitte study released today at the 2008 BIO International Convention in San Diego.

Findings from the Deloitte report support the need to measure innovation in the market, in addition to the lab. Out of six biotechnology innovations measured, the study found that four (targeted therapies, monoclonal antibodies, radiotherapy and drug device combinations) advanced significantly in 2007, marking a year of unprecedented progress and commercial impact. Targeted therapies with companion molecular diagnostics have experienced the most profound surge in realization, rising 50 percent in just three years.

Developed to track the pace and progress of therapeutic-based technologies, the Deloitte report includes both quantitative research leveraging a proprietary index model and qualitative insights and analyses based on interviews with leading life sciences industry executives.

"Given the volatility and the pace of scientific discovery in recent years, there is a need for a fact-based analysis to better understand which innovations are emerging as the most promising and, conversely, which technologies are losing ground," said Matthew Hudes, U.S. managing principal, Biotechnology, for Deloitte Consulting LLP's Life Sciences & Health Care practice, and the director of the study. "As a first step toward more personalized treatments, targeted therapies with companion diagnostics are reaching more patients. However, there remain significant economic, reimbursement and regulatory challenges that could prevent valuable treatments from becoming available to people who need them."

Using data collected over the past six years, Deloitte researchers created a three-stage measurement model coverin
'/>"/>

SOURCE Deloitte
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
2. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
3. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
4. STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30%
5. Monogram Biosciences to Present at the ThinkEquity Partners Fifth Annual Growth Conference
6. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
7. Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth
8. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
9. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
10. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
11. ADVENTRX Pharmaceuticals to Present at the ThinkEquity Partners Fifth Annual Growth Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...swire/--BiotechfirmReplikinsLtd.,whichhasanalyzedt...heprediction,outbreak,andprogressofthecurrentH1N1p...hevirus.ThenewdatashowsthatthelethalityoftheH1N1("...duringthevirus,scurrentoutbreakinthespringof2009to...eH1N1virus,infectivitycount,however,remainsincreas...
(Date:11/25/2009)...wswire-Asia/--SinovacBiotechLtd.(SVA),aleadingdev...ecuted,ajointventure(JV)agreementtoestablishSinova....TheJVwillresearch,develop,produce,andcommercializ...se,andexperienceindevelopingandcommercializingworl...ights,manufacturingfacilitiesand,establishedoperat...
(Date:11/24/2009)...wswire-FirstCall/--IES(Nasdaq: IESC ),aleadingnati...dservicesforthecommercial,industrialandresidential...uphasbeenawardedacontractfromManhattanTorconJVtoin...(BSL-4)replacementfacilityattheU.S.ArmyMedicalRese...etrickinFrederick,Md. ,, ThenewUSAMRIIDreplacem...
(Date:11/24/2009)...Ontario,Nov.24/PRNewswire-FirstCall/--DowAgroScien...andSeeds,adivisionofThompsonsLimitedofBlenheim,Ont...groSciences,currentseedsbusinessasthecompanyantici...DowAgroSciencesHerbicideTolerantTraitTechnologyinc...future. ,, "Thisacquisitionbringstogethertwostr...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...EAPOLIS, May 19 G. Arthur Herbert, a Techne Corpo...s Audit Committee, Executive Compensation Committe...ed today that he is planning to retire at the end ... shareholders reelect Directors on an annual basis...r re-nomination as a Director for fiscal year 2010...
... ALTO, Calif., May 19 Pioneering medical device c...learance from the U.S. Food and Drug Administratio...ice, the ,Signos,. , , (Photo: http://www.newsco...ics has developed a cost-effective device that for... health professionals to use ultrasound in their c...
...t-in-class Oral Therapeutic for IBD with Novel Mod...ChemoCentryx, Inc., today announced that data from...ed Oral Therapy Evaluation in Crohn,s disease Tria...(CCX282-B) in patients with moderate-to-severe Cro...at the upcoming 2009 Digestive Disease Week (DDW) ...
Other Biology Technology:Techne Corporation Announces the Retirement of G. Arthur Herbert, a Member of Its Board of Directors 2Signostics Receives FDA Clearance for World's Smallest Ultrasound Product 2ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 2ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 3ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 4ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 5
(Date:11/25/2009)... CAWhen you eat may be just as vital to your healt...nstitute for Biological Studies. Their experiments... of thousands of genes in the liverthe body,s meta...take and not by the body,s circadian clock as conv...rmines the activity of a large number of genes com...
(Date:11/24/2009)... keep weakened and flabby arteries from collapsing... those stents are no longer needed -- once the art...reviously, doctors had no choice but to leave them...University,s Department of Biomedical Engineering ...that carries drugs where they,re needed, then diss...
(Date:11/24/2009)...itutes fish food is a matter of debate. A high-pro... almost 50 percent of their carbon from trees and ... terrestrial and aquatic ecosystems. , But new r...is is not likely to be true. Algae provide a much ...ding to research published this week in the Proce...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Consciousness Helps the Mind and Body Work Together 58773 1Consciousness Helps the Mind and Body Work Together 58773 2New Classification Proposed for Stomach Cancers 58771 1New Classification Proposed for Stomach Cancers 58771 2Drug Combo May Prevent Heart Attacks Strokes 58769 1Drug Combo May Prevent Heart Attacks Strokes 58769 2Drug Combo May Prevent Heart Attacks Strokes 58769 3
...A - Topics include: onset of plate tectonics on Ea...tem; cause of the end-Permian mass extinction; Old...ins; an ancient mantle plume and the break-up of R...ng glaciers; monitoring Mt. Etna gas composition a...he PETM. The GSA TODAY science article examines Co...
...cuous species, sexual conflict runs in reverse, re...h in Current Biology, a publication of Cell Press....s who aggressively pursue their mates, while males... conflict holds that males, for whom reproducing i...er hand, females, who must pay a heftier price, ar...
...se is available in Spanish . , How did the rode...sula live six million years ago" The researcher of...answer this question through his doctoral thesis "...the Pliocene of the central section of the Guadix ...r Viseras, of the Dept. of Stratigraphy and Palae...
Other Biology News:December GEOLOGY and GSA TODAY media highlights 2December GEOLOGY and GSA TODAY media highlights 3December GEOLOGY and GSA TODAY media highlights 4December GEOLOGY and GSA TODAY media highlights 5December GEOLOGY and GSA TODAY media highlights 6December GEOLOGY and GSA TODAY media highlights 7December GEOLOGY and GSA TODAY media highlights 8December GEOLOGY and GSA TODAY media highlights 9December GEOLOGY and GSA TODAY media highlights 10In promiscuous antelopes, the 'battle of the sexes' gets flipped 2Rodent fossils allows to determine climate of the Iberian Peninsula 6 million years ago 2
Mouse Serum from CHEMICON
Cotinine ELISA Kit, Single from Bio-Quant Inc.
Immunohistochemistry - Gene Discovery from Paragon BioServices
Protein G EIA Kit from Assay Designs/Stressgen Bioreagents
Biology Products: